Emerging Therapy Solutions
Operating Status: Operating
ETS offers comprehensive healthcare solutions for high-cost therapies, specializing in cell, gene, and transplant therapies.
Emerging Therapy Solutions® (ETS) specializes in providing comprehensive healthcare solutions for high-cost therapies, with a focus on cell, gene, and transplant therapies. Founded in 2018, ETS primarily assists healthcare payers in managing the risks and costs associated with rare and complex medical conditions. The firm leverages its expertise to offer crucial insights, expert data analysis, and support to navigate the financial and logistical challenges of these advanced therapies.
ETS's notable acquisition of LifeTrac in 2020 expanded its capabilities by incorporating over 30 years of experience in bone marrow and solid organ transplants. This integration has strengthened ETS's provider relationships and agreements, enhancing its service offerings. Key partners and decision-makers at ETS are industry veterans from managed care solutions, healthcare biotech, and transplant sectors. The firm's investment philosophy centers on mitigating risks and ensuring preparedness for catastrophic claims, adding unique value to its portfolio companies through strategic planning and pricing guidance.
ETS offers comprehensive healthcare solutions for high-cost therapies, specializing in cell, gene, and transplant therapies.
Emerge
emerge.me
Total Life
totallife.com
Emerging Technology Partners
xTeros
xteros.com
Enter
enter.health
Nomi Health
nomihealth.com
HealthBridge
myhealthbridge.com
Gem Health
gem.health
Healthcare Highways
EasyHealth
easyhealth.com
Trinity Healthcare Development
Accelitech
accelitech.biz
Free Market Health
Novo Health
novohealth.com
InsurMedix
insurmedix.com